Every financial statement,
one clean chart.
Search any US-listed company. Data straight from SEC filings.
PRECIGEN, INC. (PGEN), most recent 12 months reported: revenue $9.68M, net loss $157.71M, free cash flow -$115.22M. Latest balance sheet on file: liquid cash $38.21M, total debt $93.88M, net cash -$55.67M. From SEC filings. More on PRECIGEN, INC.: Revenue · Profitability · Cash flow · Debt Others in Pharmaceutical Preparations: BIOAGE LABS, INC. · Evommune, Inc. · Zenas BioPharma, Inc. · Opus Genetics, Inc. · INTERNATIONAL STEM CELL CORPORATION · Aclaris Therapeutics, Inc. · Coya Therapeutics, Inc. · Adagene Inc.
Filter every US company by the numbers — net cash, margins, ROIC, growth. Looking for one company? The search box above is free.
Follow a company and we'll email you when it files a quarterly or annual report with the SEC. Free follows 3 companies; Pro follows up to 500, and sorts and filters them.